Board Of Trustees Of The Leland Stanford Junior University Atreca, Inc. Transaction History

Board Of Trustees Of The Leland Stanford Junior University

  • $1.17 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021
SELL
$13.0 - $19.34 $2.67 Million - $3.97 Million
-205,248 Closed
0 $0
Q2 2020

Aug 12, 2020
SELL
$12.52 - $23.45 $2.57 Million - $4.81 Million
-205,249 Reduced 50.0%
205,248 $4.37 Million
Q1 2020

May 13, 2020
SELL
$11.4 - $27.28 $304,870 - $729,549
-26,743 Reduced 6.12%
410,497 $6.79 Million
Q2 2019

Aug 12, 2019
BUY
$17.07 - $18.84 $7.46 Million - $8.24 Million
437,240 New
437,240 $8.24 Million

Others Institutions Holding BCEL

# of Institutions
2
Shares Held
30.6K
Call Options Held
0
Put Options Held
0
View Full List

About Atreca, Inc.

BCEL Quotes by TradingView
  • Ticker BCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,876,000
  • Description
  • Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-10...
More about BCEL
Track This Portfolio

Track Board Of Trustees Of The Leland Stanford Junior University Portfolio

Follow Board Of Trustees Of The Leland Stanford Junior University and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Board Of Trustees Of The Leland Stanford Junior University, based on Form 13F filings with the SEC.

News

Stay updated on Board Of Trustees Of The Leland Stanford Junior University with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email